HPT honoured as a top supplier by QIAGEN

“Supplier of the Year Award” presented

Neuhaus am Rennweg – Competence, quality, innovation – these values are not only fundamental to the Röchling company HPT, but are also important for a successful long-term supplier relationship. HPT Hochwertige Pharmatechnik GmbH & Co. KG in Neuhaus am Rennweg was honoured by their globally active top customer QIAGEN GmbH for outstanding performance in the past financial year. The renowned company awarded the “Supplier of the Year Award” for the first time, and honoured the performance of its top 20 suppliers from a total pool of around 3,600.

“We are happy to receive this award. It shows us that we are on the right track with our holistic and partnership-focused business model, and continual improvement processes”, said the pleased HPT Managing Director Karl-Heinz Sladek.

Criteria for selection of the winner were its performance in areas such as sustainability, innovation, service and quality.

Karl-Heinz Sladek and HPT Sales Manager Michael Löffler accepted the award. The award was presented by Serge Van Vooren, Vice President Purchasing at QIAGEN, and Frank Jüntgen, Associate Director – Global Category Leader Plastics & Contract Manufacturing Global Procurement.

“We thank our customer QIAGEN for the outstanding cooperation, which is based on trust, mutual respect and appreciation” said Managing Director Karl-Heinz Sladek.

HPT has been a member of the Röchling group, which stands for global plastic expertise, since the start of 2015. With the acquisition of HPT, Röchling further continued its strategic expansion into the medical engineering sector. As a specialist for the manufacture of primary packaging made of plastic, HPT and their global customers benefit from close cooperation within the global corporate network of the Röchling group.

QIAGEN is a leading global supplier of complete solutions for the extraction of valuable molecular insights from biological samples. The sample technologies from QIAGEN make it possible to purify and process DNS, RNS and proteins from blood, tissues and other materials. Test technologies make these biomolecules visible and ready for analysis. Bioinformatic solutions and knowledge databases help with the interpretation of data for the extraction of relevant and practically usable results. Automation solutions seamlessly and cost-efficiently integrate these into molecular test work flows. QIAGEN makes these work flows available worldwide to more than 500,000 customers from the sectors of molecular diagnostics (health care), applied testing (forensics, veterinary diagnostics and food safety), pharmaceuticals (pharmaceutical and biotechnology companies) and research (life sciences).

HPT is proud to support QIAGEN in these highly sophisticated processes and medically important work with plastic primary packaging.

1

After the presentation (from left): Serge Van Vooren, (QIAGEN – Vice President Purchasing), Frank Jüntgen (QIAGEN – Associate Director-Global Category Leader Plastics & Contract Manufacturing Global Procurement), Thomas Großmann (HPT – Project Manager R&D), Michael Löffler (HPT – Sales Director), Guido Drees (Röchling – General Manager Operations, Medical Plastics Dept.), Karl-Heinz Sladek (HPT – Managing Director), Julia Tröbs (HPT – Sales Account Manager). Image: HPT